How much funding has Velano Vascular raised?

Velano Vascular has raised $50.9M in total funding, most recently a Series A round.

Who are Velano Vascular's investors?

Velano Vascular's investors include First Round Capital, Kaiser Permanente Ventures, Northwell Health, Intermountain Healthcare.

When was Velano Vascular founded?

Velano Vascular was founded in 2012.

Where is Velano Vascular headquartered?

Velano Vascular is headquartered in San Francisco, California, United States.

What industry is Velano Vascular in?

Velano Vascular operates in Healthcare.

How many employees does Velano Vascular have?

Velano Vascular has 11-50 employees.

Velano Vascular

San Francisco, United States · Founded 2012 · $50.9M raised

Healthcare

Headquarters: San Francisco, California
Employees: 11–50
Founded: 2012
Business Model: B2B

Website: velanovascular.com
Total Funding: $50.9M
Last Round: $5.0M Series ADec 2019
Rounds: 5

About

Velano Vascular is a San Francisco-based medical device company founded in 2012 that developed PIVO, a breakthrough needle-free blood collection device for hospitalized patients. PIVO attaches to an existing peripheral IV catheter and advances a flexible inner tube to collect fresh blood samples without additional needle sticks, reducing patient pain, hemolysis rates, and nursing time burden. The company's technology was adopted by major health systems including Sutter Health and earned recognition as one of Fast Company's Most Innovative Companies in the World. Velano Vascular was acquired by BD (Becton, Dickinson and Co.) in July 2021, and its PIVO technology continues as the BD PIVO Pro product line.

Summary

Velano Vascular is a Healthcare company based in San Francisco, United States, founded in 2012. It has raised $50.9M in total across 5 rounds, most recently a $5.0M Series A round in Dec 2019. Investors include First Round Capital, Kaiser Permanente Ventures and Northwell Health.